Position in JANX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$9,784,762
+$1,251,051 QoQ
Shares Held
703,940
+13.8% QoQ
Ownership
1.15%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in JANX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $15,440,401,210 across 521 Biotechnology names. JANX ranks #133 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
43,571,633 | $2,090,131,227 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
51,828,325 | $1,435,644,595 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,188,881 | $1,423,962,911 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,319,329 | $1,019,366,352 | |
| 5 | TECH |
BIO-TECHNE Corp
|
8,532,873 | $445,927,935 | |
| 6 | MRNA |
Moderna, Inc.
|
8,471,263 | $430,340,154 | |
| 7 | ARGX |
Argenx SE
|
560,711 | $409,459,203 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
10,042,399 | $404,005,708 |
All Filings in JANX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,784,762 | 703,940 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $8,533,711 | 618,385 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $12,113,316 | 495,635 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $7,293,382 | 315,731 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $7,625,529 | 282,427 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $11,662,667 | 217,831 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $6,381,276 | 140,464 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $3,426,514 | 81,798 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $4,564,342 | 121,231 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $723,712 | 67,448 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $206,193 | 20,456 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $219,367 | 18,481 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $405,395 | 33,504 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $230,262 | 17,484 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,915,637 | 141,480 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $338,617 | 27,733 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $397,832 | 27,743 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $285,668 | 14,479 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $144,963 | 6,702 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,495 | 100 | Shares | Defined | 2021-08-23 | |
| No filing history on record for this holder in this stock. | ||||||